Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment
International Journal of Pharmaceutics: X · 2026-11 · 100709
DOI: 10.1016/j.ijpx.2026.100709 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutics: X, 2026-11. Verfasst von Shuaiwen Hu und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hu, S., Li, B., Su, M., Liu, Q., Liang, Y., Xia, J., & Pan, X. (2026). Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment. International Journal of Pharmaceutics: X, 100709. https://doi.org/10.1016/j.ijpx.2026.100709
Vancouver
Hu S, Li B, Su M, Liu Q, Liang Y, Xia J, et al. Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment. International Journal of Pharmaceutics: X. 2026:100709. doi:10.1016/j.ijpx.2026.100709
BibTeX
@article{Hu2026,
author = {Hu, Shuaiwen and Li, Biquan and Su, Meng and Liu, Qisong and Liang, Yujie and Xia, Jiang and Pan, Xiaohua},
title = {Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment},
journal = {International Journal of Pharmaceutics: X},
year = {2026},
pages = {100709},
doi = {10.1016/j.ijpx.2026.100709}
}
EUVIMED